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2674with underlying CVD and poor preparation account-
ing for most events (2). The epidemiological beneﬁts
of exercise could even be stronger at high doses, with
research in much larger cohorts revealing greater
gains in life expectancy (þ4.5 years; 95% CI: 4.3 to
4.7) when exercising $450 min/week (3). Evidence
also exists of exercise-related survival beneﬁts in
extreme endurance exercisers. In a recent meta-
analysis, we detected considerably lower all-cause
(0.67; 95% CI: 0.55 to 0.81; p < 0.001) and CVD-
related standard mortality ratios (0.73; 95% CI: 0.65
to 0.82; p < 0.001) in professional athletes (n ¼
42,807, including marathoners) versus the general
population (4). These data are consistent with
those from large cohorts of Scandinavian endurance
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Recurring Reverse J- or U-CurvesWe thank Dr. Andersen, Drs. Burtscher and Pesta,
Drs. Charansonney and Cohen-Solal, Mr. Maessen andcolleagues, and Dr. Sanchis-Gomar and colleagues for
the interest in our paper and their many insightful
comments (1).
The 1986 paper by Paffenbarger et al. was the
ﬁrst of many studies to report a U-shaped associa-
tion between leisure-time physical activity and
mortality. In the short interim since our study was
published in the Journal, 2 more large prospective
observational studies have reported similar U-sha-
ped or reverse J-shaped associations. The recurring
theme is that moderate doses of exercise markedly
reduce risks for long-term mortality (both all-cause
and cardiovascular deaths), but the subgroups that
perform very high doses of exercise appear to lose
some of the mortality beneﬁt conferred by moder-
ate exercise. The Million Women Study (2) found
that regular physical activity was associated with
dramatically lower risks of coronary heart disease
(CHD); however, the women who did not take at
least 1 day/week off of strenuous exercise appeared
to lose some of the cardioprotection (Figure 1A).
Another large study recently reported that exercise
dramatically reduced the risk of death during
follow-up (3); however, again, the maximal beneﬁts
were noted in the moderate range, with the
familiar reverse J-curve suggesting an attenuation
of beneﬁt at the highest level of exercise
(Figure 1B). In 2013, we published a study of a
random sample of 1,878 joggers who were followed
for up to 35 years and compared with 16,827 non-
joggers. The increase in survival among joggers was
similar between the sexes (6.2 years in men
and 5.6 years in women), but surprisingly those
who jogged for the longest time (>4 h/week), at a
fast pace, and >3 times/week appeared to lose
much of the longevity beneﬁt that was noted with
less strenuous jogging (4).
We analyzed the association between mortality
and quantity, pace, and frequency of jogging, both
individually and combined, in 1,098 healthy joggers
and 3,950 healthy nonjoggers; the reference group
was the 413 nonjoggers who reported being seden-
tary during leisure time. The analyses of pace and
frequency of jogging suggested a U-shape. In the
combined analysis, we found that light joggers had
the lowest hazard ratio compared with sedentary
nonjoggers. We also found that moderate joggers
had a signiﬁcantly higher hazard ratio compared
with light joggers. This ﬁnding suggested a U-shape
between jogging dose and mortality. The strenuous
joggers also had a signiﬁcantly higher hazard ratio
compared with light joggers. In addition, we
FIGURE 1 Coronary Heart Disease Was Reduced by Regular Strenuous Physical Activity
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(A) Coronary heart disease was reduced by regular strenuous physical activity (4);
however, this beneﬁt was attenuated when strenuous exercise was performed
7 days/week. (B) Hazard ratios and 95% conﬁdence intervals for leisure time moderate- to
vigorous-intensity physical activity and CVD mortality. Some loss of beneﬁt may occur at
very high doses, for example, at $750 min/week of vigorous exercise, which is approxi-
mately 10-fold higher than the minimum recommended by guidelines (3). CVD ¼ cardio-
vascular disease; gsCI ¼ group-speciﬁc conﬁdence interval; MET ¼ metabolic equivalent.
J A C C V O L . 6 5 , N O . 2 4 , 2 0 1 5 Letters
J U N E 2 3 , 2 0 1 5 : 2 6 6 7 – 7 6
2675reported that the hazard ratio for strenuous joggers
compared with sedentary nonjoggers was insigniﬁ-
cant. We acknowledge that the power to detect a
difference was low.
We found that a relative scale of pace (intensity) is
more appropriate than an absolute scale (miles/h)
when the age span is wide (20 to 95 years) and
when the participants have wide differences in levels
of physical ﬁtness. Thus, we simply estimated the
speed by using the subject’s own perception of pace
(slow, average, fast). This technique for assessing
relative intensity of exercise was proven effective
for assessing the effects of training.
It is correct that we analyzed the impact of in-
tensity and duration of walking and cycling on mor-
tality in previous studies and found that the relative
intensity was of more importance than the duration.
Nevertheless, this ﬁnding is not contradictory to
our new ﬁndings, because even fast walking and
leisurely cycling are not as intense as slow jogging,
which qualiﬁes as vigorous exercise (6 metabolic
equivalents).
The most important take-away message from all of
these studies is that exercise, such as running or
jogging, confers powerful beneﬁts for health and
longevity (1–3). A less certain corollary emerging from
these data suggests that some of the beneﬁts of reg-
ular physical activity may be attenuated at very high
doses of long-term intense exercise. More than 50%
of the U.S. adult population performs insufﬁcient
physical activity, whereas the subgroup of Americans
who may be overdoing exercise is perhaps 2% to 3%
(5). The small size of the cohort of over-exercisers
makes the upturn at the end of the reverse J- and U-
curves less statistically signiﬁcant. However, in
studies with large numbers, such as the 1.1 million
women from the United Kingdom (2), the 35,000
women (3.2%) who exercised strenuously 7 days/
week experienced a statistically signiﬁcant loss of
most or all of the protection against CHD, stroke, and
venous thromboembolism that was noted among the
moderate exercise groups. Furthermore, focusing on
higher risk groups, such as those with previous CHD,
also improved the statistical power and made the loss
of beneﬁt among the high-dose exercise cohort sta-
tistically signiﬁcant.
All 3 of the co-authors of this response strongly
advocate for the beneﬁts of exercise, including
jogging, to our patients and our own family and
friends. The ﬁrst jogging race, to our knowledge in
Europe (the Eremitage Race), took place in Copen-
hagen in 1969, and was initiated and is still con-
trolled by Peter Schnohr. Still, we also emphasize
that if one is exercising to improve long-termcardiovascular health and longevity, it may be
best to aim for moderate rather than extreme ef-
forts, or at least take 1 day a week off of strenuous
exercise.
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